Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis

Young Ho Lee, Sang Cheol Bae

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aim: This study aimed to evaluate the relationship between circulating adiponectin and visfatin levels and rheumatoid arthritis (RA) and to establish a correlation between serum adipokine levels and RA activity. Methods: We conducted meta-analyses on serum/plasma adiponectin or visfatin levels in patients with RA and controls and correlation coefficients between circulating adiponectin and visfatin levels and Disease Activity Score of 28 joints (DAS28) in RA patients. Results: Eleven studies comprising 813 RA patients and 684 controls were included in this meta-analysis. The meta-analysis revealed that adiponectin levels were significantly higher in the RA group than in the control group (standardized mean difference [SMD] = 1.529, 95% confidence interval [CI] = 0.354−2.704, P = 0.011). Circulating adiponectin level was not associated with RA activity based on DAS28 and C-reactive protein (CRP) levels. Visfatin levels were significantly higher in the RA group than in the control group (SMD = 2.575, 95% CI: = 0.963–4.189, P = 0.002). A trend of positive correlation among circulating visfatin levels and DAS28 and CRP levels was found (correlation coefficient = 0.416, 95% CI: = −0.917 to 0.795, P = 0.177; correlation coefficient = 0.366, 95% CI: = −0.074 to 0.687, P = 0.101, respectively). Conclusions: Our meta-analysis demonstrated that circulating adiponectin levels were significantly higher in patients with RA than in controls. Circulating visfatin levels were significantly higher in patients with RA than in controls and a positive correlation between circulating visfatin level and RA activity is suggested.

Original languageEnglish
Pages (from-to)664-672
Number of pages9
JournalInternational Journal of Rheumatic Diseases
Volume21
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

Nicotinamide Phosphoribosyltransferase
Adiponectin
Meta-Analysis
Rheumatoid Arthritis
Confidence Intervals
Joints
C-Reactive Protein
Control Groups
Adipokines
Serum

Keywords

  • adiponectin
  • rheumatoid arthritis
  • visfatin

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{bd21d0922c7b449d9f2edcd1dc49e942,
title = "Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis",
abstract = "Aim: This study aimed to evaluate the relationship between circulating adiponectin and visfatin levels and rheumatoid arthritis (RA) and to establish a correlation between serum adipokine levels and RA activity. Methods: We conducted meta-analyses on serum/plasma adiponectin or visfatin levels in patients with RA and controls and correlation coefficients between circulating adiponectin and visfatin levels and Disease Activity Score of 28 joints (DAS28) in RA patients. Results: Eleven studies comprising 813 RA patients and 684 controls were included in this meta-analysis. The meta-analysis revealed that adiponectin levels were significantly higher in the RA group than in the control group (standardized mean difference [SMD] = 1.529, 95{\%} confidence interval [CI] = 0.354−2.704, P = 0.011). Circulating adiponectin level was not associated with RA activity based on DAS28 and C-reactive protein (CRP) levels. Visfatin levels were significantly higher in the RA group than in the control group (SMD = 2.575, 95{\%} CI: = 0.963–4.189, P = 0.002). A trend of positive correlation among circulating visfatin levels and DAS28 and CRP levels was found (correlation coefficient = 0.416, 95{\%} CI: = −0.917 to 0.795, P = 0.177; correlation coefficient = 0.366, 95{\%} CI: = −0.074 to 0.687, P = 0.101, respectively). Conclusions: Our meta-analysis demonstrated that circulating adiponectin levels were significantly higher in patients with RA than in controls. Circulating visfatin levels were significantly higher in patients with RA than in controls and a positive correlation between circulating visfatin level and RA activity is suggested.",
keywords = "adiponectin, rheumatoid arthritis, visfatin",
author = "Lee, {Young Ho} and Bae, {Sang Cheol}",
year = "2018",
month = "3",
day = "1",
doi = "10.1111/1756-185X.13038",
language = "English",
volume = "21",
pages = "664--672",
journal = "International Journal of Rheumatic Diseases",
issn = "1756-1841",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity

T2 - A meta-analysis

AU - Lee, Young Ho

AU - Bae, Sang Cheol

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Aim: This study aimed to evaluate the relationship between circulating adiponectin and visfatin levels and rheumatoid arthritis (RA) and to establish a correlation between serum adipokine levels and RA activity. Methods: We conducted meta-analyses on serum/plasma adiponectin or visfatin levels in patients with RA and controls and correlation coefficients between circulating adiponectin and visfatin levels and Disease Activity Score of 28 joints (DAS28) in RA patients. Results: Eleven studies comprising 813 RA patients and 684 controls were included in this meta-analysis. The meta-analysis revealed that adiponectin levels were significantly higher in the RA group than in the control group (standardized mean difference [SMD] = 1.529, 95% confidence interval [CI] = 0.354−2.704, P = 0.011). Circulating adiponectin level was not associated with RA activity based on DAS28 and C-reactive protein (CRP) levels. Visfatin levels were significantly higher in the RA group than in the control group (SMD = 2.575, 95% CI: = 0.963–4.189, P = 0.002). A trend of positive correlation among circulating visfatin levels and DAS28 and CRP levels was found (correlation coefficient = 0.416, 95% CI: = −0.917 to 0.795, P = 0.177; correlation coefficient = 0.366, 95% CI: = −0.074 to 0.687, P = 0.101, respectively). Conclusions: Our meta-analysis demonstrated that circulating adiponectin levels were significantly higher in patients with RA than in controls. Circulating visfatin levels were significantly higher in patients with RA than in controls and a positive correlation between circulating visfatin level and RA activity is suggested.

AB - Aim: This study aimed to evaluate the relationship between circulating adiponectin and visfatin levels and rheumatoid arthritis (RA) and to establish a correlation between serum adipokine levels and RA activity. Methods: We conducted meta-analyses on serum/plasma adiponectin or visfatin levels in patients with RA and controls and correlation coefficients between circulating adiponectin and visfatin levels and Disease Activity Score of 28 joints (DAS28) in RA patients. Results: Eleven studies comprising 813 RA patients and 684 controls were included in this meta-analysis. The meta-analysis revealed that adiponectin levels were significantly higher in the RA group than in the control group (standardized mean difference [SMD] = 1.529, 95% confidence interval [CI] = 0.354−2.704, P = 0.011). Circulating adiponectin level was not associated with RA activity based on DAS28 and C-reactive protein (CRP) levels. Visfatin levels were significantly higher in the RA group than in the control group (SMD = 2.575, 95% CI: = 0.963–4.189, P = 0.002). A trend of positive correlation among circulating visfatin levels and DAS28 and CRP levels was found (correlation coefficient = 0.416, 95% CI: = −0.917 to 0.795, P = 0.177; correlation coefficient = 0.366, 95% CI: = −0.074 to 0.687, P = 0.101, respectively). Conclusions: Our meta-analysis demonstrated that circulating adiponectin levels were significantly higher in patients with RA than in controls. Circulating visfatin levels were significantly higher in patients with RA than in controls and a positive correlation between circulating visfatin level and RA activity is suggested.

KW - adiponectin

KW - rheumatoid arthritis

KW - visfatin

UR - http://www.scopus.com/inward/record.url?scp=85013329012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013329012&partnerID=8YFLogxK

U2 - 10.1111/1756-185X.13038

DO - 10.1111/1756-185X.13038

M3 - Article

C2 - 28205390

AN - SCOPUS:85013329012

VL - 21

SP - 664

EP - 672

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

SN - 1756-1841

IS - 3

ER -